WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- Capital expenditures, 2025
- $286M
- YoY, 2025
- −24.2%
- 5-year CAGR
- +10.4%
- 10-year CAGR
- +8.1%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $286M | −24.2% |
| 2024 | $377M | +4.1% |
| 2023 | $362M | +27.2% |
| 2022 | $285M | +12.3% |
| 2021 | $253M | +45.3% |
| 2020 | $174M | +38.0% |
| 2019 | $126M | +20.7% |
| 2018 | $105M | −20.0% |
| 2017 | $131M | −23.1% |
| 2016 | $170M | +29.3% |
| 2015 | $132M | +17.6% |
| 2014 | $112M | −26.3% |
| 2013 | $152M | +15.7% |
| 2012 | $131M | +37.6% |
| 2011 | $95M | +34.2% |
| 2010 | $71M | −32.2% |
| 2009 | $105M | −24.3% |
| 2008 | $139M | — |